PATIENT OUTCOMES 6 AND 12 MONTHS AFTER ALTA, EDEN AND OMEGA ARDS NETWORK TRIAL

ALTA、EDEN 和 OMEGA ARDS 网络试验后 6 个月和 12 个月的患者结果

• 批准号: 8167040
• 负责人: PETER E MORRIS
• 金额: $ 0.75万
• 依托单位: WAKE FOREST UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-03-01 至 2011-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8167040
• 关键词: Affect; Clinical Trials; Cognition; Cognitive; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Health Status; Incidence; Institution; Longitudinal Studies; Mental Health; Morbidity - disease rate; Outcome; Parents; Patients; Populations at Risk; Research; Research Personnel; Resources; Source; Survivors; Testing; United States National Institutes of Health; aging population; base; improved; mortality; muscle strength; research clinical testing; Affect; Clinical Trials; Cognition; Cognitive; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Health Status; Incidence; Institution; Longitudinal Studies; Mental Health; Morbidity - disease rate; Outcome; Parents; Patients; Populations at Risk; Research; Research Personnel; Resources; Source; Survivors; Testing; United States National Institutes of Health; aging population; base; improved; mortality; muscle strength; research clinical testing

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The incidence of ALI is higher than previously recognized and the number of survivors is growing due to improving ICU mortality and an aging population at risk for ALI. However, these survivors endure many long-term morbidities. To date, the vast majority of clinical trials in ALI have not considered these long-term outcomes, instead focusing exclusively on short-term mortality-based end points. To advance this field, larger-sized longitudinal studies are needed to comprehensively understand the long-term physical, cognitive and mental health status of survivors and to test how specific ICU therapies may affect these outcomes. Our proposal makes the following important contribution: in-depth clinical evaluation of muscle strength, anthropometrics and cognition which have been incompletely evaluated in prior studies but are likely commonly and severely impaired in survivors, and potentially improved by the ICU therapies tested in the parent trials.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 ALI的发病率高于以前认识的，由于ICU死亡率提高和人口老龄化的ALI风险，幸存者的数量正在增长。但是，这些幸存者忍受了许多长期的病毒。迄今为止，ALI的绝大多数临床试验尚未考虑这些长期结果，而是专注于基于短期死亡率的终点。为了推进这一领域，需要大大型的纵向研究，以全面了解幸存者的长期身体，认知和心理健康状况，并测试特定的ICU疗法如何影响这些结果。我们的建议做出了以下重要贡献：对肌肉力量，人类学和认知的深入临床评估，这些肌肉力量，人类学和认知未完全在先前的研究中进行了评估，但可能在幸存者中通常会受到严重损害，并且在父母试验中测试的ICU疗法有可能改善。